Hostname: page-component-745bb68f8f-cphqk Total loading time: 0 Render date: 2025-01-11T22:56:20.106Z Has data issue: false hasContentIssue false
  • English
  • Français

From Community to Commodity: The Ethics of Pharma-Funded Social Networking Sites for Physicians

Published online by Cambridge University Press:  01 January 2021

Amy Snow Landa  and
Carl Elliott
Get access Rights & Permissions [Opens in a new window]

Extract

In September 2006, a small start-up company in Cambridge, MA called Sermo, Inc., launched a social networking site with an unusual twist: only physicians practicing medicine in the United States would be allowed to participate. Sermo, which means “conversation” in Latin, marketed its website as an online community exclusively for doctors that would allow them to talk openly (and anonymously) about a range of topics, from challenging and unusual medical cases to the relative merits of one treatment versus another. “Sermo enables the private and instant exchange of knowledge among MDs,” the company announced in its first press release. Even better, participation was free and the site carried no advertising.

Type
Symposium
Information
Journal of Law, Medicine & Ethics , Volume 41 , Issue 3 , Fall 2013 , pp. 673 - 679
Copyright
Copyright © American Society of Law, Medicine and Ethics 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

“Sermo Physician Community Launches – Marks New Era for Bedside Observation,” Businesswire.com, September 26, 2006, available at <http://www.businesswire.com/news/home/20060926005403/en/Sermo-Physician-Community-Launches—Marks-Era> (last visited June 19, 2013).+(last+visited+June+19,+2013).>Google Scholar
“Replacing the Hospital Water Cooler,” Medicine on the Net, March 2007, 1–3, at 3, available at <http://www.hcpro.com/content/67540.pdf> (last viewed June 19, 2013).+(last+viewed+June+19,+2013).>Google Scholar
On Sermo, physicians are required to provide personal information only when they register on the site, so that the company can confirm they are licensed to practice medicine in the United States. See “Discuss + Connect,” Sermo.com, available at <http://www.sermo.com/take-a-tour/discuss-connect> (last viewed June 19, 2013).+(last+viewed+June+19,+2013).>Google Scholar
“Earn Honoria,” Sermo.com, available at <http://www.sermo.com/take-a-tour/earn-honoraria> (last viewed June 19, 2013).+(last+viewed+June+19,+2013).>Google Scholar
Sermo homepage, available at <http://www.sermo.com/> (last viewed June 19, 2013).+(last+viewed+June+19,+2013).>Google Scholar
Bureau of Labor Statistics, U.S. Department of Labor, Occupational Outlook Handbook, 2012–2013 Edition, Physicians and Surgeons, available at <http://www.bls.gov/ooh/healthcare/physicians-and-surgeons.htm> (last viewed June 19, 2013).+(last+viewed+June+19,+2013).>Google Scholar
Reece, R. L., “A Conversation with the Founder of Sermo,” Health Leaders Media, October 18, 2007, available at <http://www.healthleadersmedia.com/content/PHY-200363/A-Conversation-With-the-Founder-of-Sermo.html> (last viewed June 18, 2013).Google Scholar
See “Replacing the Hospital Water Cooler,” supra note 2.Google Scholar
“Sermo Closes $3 Million in Series A Round Funding from Longworth Venture Partners,” Businesswire.com, September 26, 2006, available at <http://www.businesswire.com/news/home/20060926005393/en/Sermo-Closes-3-Million-Series-Funding-Longworth> (last viewed June 18, 2013).+(last+viewed+June+18,+2013).>Google Scholar
Calnan, C., “Sermo Socks Away $27M in Third Funding Round,” Boston Business Journal, September 11, 2007, available at <http://www.bizjournals.com/boston/blog/mass-hightech/2007/09/sermo-socks-away-27m-in-third-funding-round.html/> (last visited April 8, 2013).+(last+visited+April+8,+2013).>Google Scholar
Id.Google Scholar
“Sermo Partners with Penn Center for Bioethics to Develop Ethical Guidelines for Market-Based Clinical Informatics,” Businesswire.com, October 27, 2006, available at <http://www.businesswire.com/news/home/20061027005361/en/Sermo-Partners-Penn-Center-Bioethics-Develop-Ethical> (last visited June 18, 2013).+(last+visited+June+18,+2013).>Google Scholar
Robeznieks, A., “Ethicist Inks Deal with For-Profit,” Modern Healthcare 36, no. 45 (November 13, 2006): 8–9.Google Scholar
Vox, F., “When Doctors Talk …,” Newsweek, March 9, 2009, available at <http://www.thedailybeast.com/newsweek/2009/03/09/when-doctors-talk.html> (last viewed June 18, 2013).+(last+viewed+June+18,+2013).>Google Scholar
Id.Google Scholar
The FDA went against the advisory panel's recommendation and asked Dendreon to provide more evidence of safety and efficacy before granting approval of Provenge in April 2010.Google Scholar
Halperin, A., “The Wisdom of the Medical Crowd,” Businessweek, April 29, 2007, available at <http://www.businessweek.com/stories/2007-04-29/the-wisdom-of-the-medical-crowd-businessweek-business-news-stock-market-and-financial-advice> (last viewed June 18, 2013).+(last+viewed+June+18,+2013).>Google Scholar
Id.Google Scholar
Id.Google Scholar
Chase, J., “Sermo, Bloomberg Partner on Service for Healthcare Investors,” Medical Marketing & Media, October 23, 2008, available at <http://www.mmm-online.com/sermo-bloomberg-partner-on-service-for-healthcare-investors/article/119831/> (last viewed June 18, 2013).+(last+viewed+June+18,+2013).>Google Scholar
Johnson, A., “Pfizer-Doctors Web Pact May Get Looks,” Wall Street Journal, October 15, 2007, at 84.Google Scholar
Hensley, S., “Pfizer Follows Docs Online with Sermo,” Wall Street Journal, October 15, 2007, available at <http://blogs.wsj.com/health/2007/10/15/pfizer-follows-docs-online-with-sermo/> (last viewed June 19, 2013).+(last+viewed+June+19,+2013).>Google Scholar
Bordoloi, P. Gazo, A. Paranjpe, K. Clausen, M. Fierro, L., “Medical Information Services: The Age of Social Media and New Customer Channels,” Drug Information Journal 45, no. 6 (2011): 811–818, at 812.CrossRefGoogle Scholar
Id., at 812.Google Scholar
Sanofi Aventis, Sanofi-Aventis U.S., U.S. Educational Grant Transparency Report, 1st Quarter 2009, available at <https://www.sagrants.com/docs/Grant_Transparency_report_qtr01_09.pdf> (last viewed June 18, 2013).+(last+viewed+June+18,+2013).>Google Scholar
University of Pennsylvania, “‘The New Business of Medicine’ Series,” available at <http://www.cesearchengine.com/ce_details.php?ce_id=5654> (last viewed April 8, 2013).+(last+viewed+April+8,+2013).>Google Scholar
Arnold, M., “Pharmas, Wall Streeters Lurk on ‘MySpace for Docs,’” Medical Marketing & Media, May 2007, at 8.Google Scholar
Id.Google Scholar
See, Sismondo, S., “Key Opinion Leaders and the Corruption of Medical Knowledge: What the Sunshine Act Will and Won't Cast Light On,” Journal of Law, Medicine & Ethics 41, no. 3 (2013): 635–643.CrossRefGoogle Scholar
Cutting Edge Information, “Pharmaceutical Thought Leaders: Brand Strategies and Product Positioning,” Report PH64 (2004).Google Scholar
Coleman, J. S. Katz, E. Manzel, H., Medical Innovation: A Diffusion Study (New York: Bobbs-Merrill Co., 1966).Google Scholar
“Sermo Business Solutions Capabilities,” available through <http://www.sermo.com/solutions> (last viewed June 18, 2013).+(last+viewed+June+18,+2013).>Google Scholar
Arnold, M., “Sermo Revamp Aims for Faster Searchers, Better Filters, Alerts,” Medical Marketing & Media, July 14, 2010, available at <http://www.mmm-online.com/sermo-revampaims-for-faster-searches-better-filters-alerts/article/174608/> (last viewed June 19, 2013).+(last+viewed+June+19,+2013).>Google Scholar
See, Rodwin, M., “Five Un-Easy Pieces to Pharmaceutical Policy Reform,” Journal of Law, Medicine & Ethics 41, no. 3 (2013): 581–589.CrossRefGoogle Scholar
Parmar, A., “Sermo vs. Doximity: Can They Coexist in Fight to Build Physician-Only Networks?” MedCity News, March 21, 2012, available at <http://medcitynews.com/2012/03/sermo-vs-doximity-can-they-co-exist-in-fight-to-build-physician-only-networks/> (last viewed June 19, 2013).+(last+viewed+June+19,+2013).>Google Scholar
Id.Google Scholar
Tangney, Jeff, interview by Williams, David E., Health Business Blog (March 8, 2012), at <http://www.healthbusinessblog.com/2012/03/doximity-professional-network-for-physicians-transcript/> (last viewed June 19, 2013).+(last+viewed+June+19,+2013).>Google Scholar
Id.Google Scholar
Wilson, D., “Drug App Comes Free, Ads Included,” New York Times, July 29, 2011, at B1.Google Scholar
See in this issue of the Journal of Law, Medicine & Ethics 41, no. 3 (2013): Sah, S. Fugh-Berman, A., “Physicians under the Influence: Social Psychology and Industry Marketing Strategies,” at 665–672, and Light, D. W. Lexchin, J. Darrow, J., “Institutional Corruption of Pharmaceuticals and the Myth of Safe and Effective Drugs,” at 590–600.CrossRefGoogle Scholar